Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs using the American College of Rheumatology Definition of Early RA.

MLA

Varela-Rosario, Noemí, et al. “Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs Using the American College of Rheumatology Definition of Early RA.” The Open Rheumatology Journal, vol. 11, Dec. 2017, pp. 136–44. EBSCOhost, https://doi.org/10.2174/1874312901711010136.

APA

Varela-Rosario, N., Arroyo-Ávila, M., Fred-Jiménez, R. M., Díaz-Correa, L. M., Pérez-Ríos, N., Rodríguez, N., Ríos, G., & Vilá, L. M. (2017). Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs using the American College of Rheumatology Definition of Early RA. The Open Rheumatology Journal, 11, 136–144. https://doi.org/10.2174/1874312901711010136

Chicago

Varela-Rosario, Noemí, Mariangelí Arroyo-Ávila, Ruth M Fred-Jiménez, Leyda M Díaz-Correa, Naydi Pérez-Ríos, Noelia Rodríguez, Grissel Ríos, and Luis M Vilá. 2017. “Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs Using the American College of Rheumatology Definition of Early RA.” The Open Rheumatology Journal 11 (December): 136–44. doi:10.2174/1874312901711010136.